You need to enable JavaScript to run this app.
FDA updates bladder cancer drug guidance, expands single-arm study recommendations
Regulatory News
Ferdous Al-Faruque
Guidance
Pharmaceuticals
Regulatory Intelligence/Policy
United States
US Food and Drug Administration (FDA)